Compare HLN & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | EAD |
|---|---|---|
| Founded | 2022 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Finance/Investors Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8B | 377.0M |
| IPO Year | 2021 | N/A |
| Metric | HLN | EAD |
|---|---|---|
| Price | $9.26 | $6.17 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.3M | 206.8K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | 1.94% | ★ 8.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.55 | N/A |
| Revenue Next Year | $4.42 | N/A |
| P/E Ratio | $49.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.65 | $6.24 |
| 52 Week High | $11.28 | $7.10 |
| Indicator | HLN | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 34.99 | 23.38 |
| Support Level | $8.77 | N/A |
| Resistance Level | $9.29 | $6.44 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 12.07 | 19.98 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Allspring Income Opportunities Fund is a diversified closed-end management investment company. The Fund seeks a high level of current income. Capital appreciation is a secondary objective. The fund has single operating segment.